Norflex and Pain - eye - a phase IV clinical study of FDA data

Summary:

Pain - eye is reported only by a few people who take Norflex.

The phase IV clinical study analyzes which people take Norflex and have Pain - eye. It is created by eHealthMe based on reports of 1,569 people who have side effects while taking Norflex from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 11, 2022

1,569 people reported to have side effects when taking Norflex.
Among them, 3 people (0.19%) have Pain - eye.


What is Norflex?

Norflex has active ingredients of orphenadrine citrate. It is often used in muscle spasms. eHealthMe is studying from 1,758 Norflex users for its effectiveness, alternative drugs and more.

What is Pain - eye?

Pain - eye is found to be associated with 2,904 drugs and 2,231 conditions by eHealthMe.

Number of Norflex and Pain - eye reports submitted per year:

Could Norflex cause Pain - eye?

Gender of people who have Pain - eye when taking Norflex *:

  • female: 66.67 %
  • male: 33.33 %

Age of people who have Pain - eye when taking Norflex *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Norflex *:

  1. Wellbutrin Sr: 1 person, 33.33%
  2. Vioxx: 1 person, 33.33%
  3. Vicodin: 1 person, 33.33%
  4. Tylenol: 1 person, 33.33%
  5. Toprol-Xl: 1 person, 33.33%
  6. Skelaxin: 1 person, 33.33%
  7. Ribavirin: 1 person, 33.33%
  8. Peg-Intron: 1 person, 33.33%
  9. Oxycontin: 1 person, 33.33%
  10. Norvasc: 1 person, 33.33%

Common side effects people have besides Pain - eye *:

  1. Weight Loss: 1 person, 33.33%
  2. Headache (pain in head): 1 person, 33.33%
  3. Apnea (temporary absence or cessation of breathing): 1 person, 33.33%
  4. Back Injury: 1 person, 33.33%
  5. Cardiac Disorder: 1 person, 33.33%
  6. Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 1 person, 33.33%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 33.33%
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 33.33%
  9. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 33.33%
  10. Cough: 1 person, 33.33%

Common conditions people have *:

  1. Hepatitis C: 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Norflex and have Pain - eye?

Check whether Pain - eye is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Norflex:

Pain - eye treatments and more:

COVID vaccines that are related to Pain - eye:

How severe was Pain - eye and when was it recovered:

Expand to all the drugs that have ingredients of orphenadrine citrate:

Common drugs associated with Pain - eye:

All the drugs that are associated with Pain - eye:

Common conditions associated with Pain - eye:

All the conditions that are associated with Pain - eye:

How the study uses the data?

The study uses data from the FDA. It is based on orphenadrine citrate (the active ingredients of Norflex) and Norflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: